Navigation Links
Reduction in Drug Costs

Research in Norway has shown that there have been substantial savings in drug costs since the introduction of a regulation requiring doctors to prescribe the recommended first-line treatment for hypertension (high blood pressure).

Since March 2004, family doctors have been reimbursed for drug costs only if they prescribe thiazides as first-line therapy for uncomplicated hypertension, unless there are medical reasons for selecting other drugs.

Atle Fretheim and colleagues, in a research article published in PLoS Medicine, show that the change in prescribing practices reduced drug costs per Norwegian by US$0.16 in the first year.

Antihypertensive drugs are a major part of national drug expenditure in developed countries, where as many as one person in ten is treated for hypertension. The different classes of antihypertensive are all effective but their costs vary widely. Thiazides, for example, are a tenth of the price of many non-thiazide drugs.

In Norway, as in many other developed countries, guidelines were introduced to encourage doctors to use thiazides but the level of their use remained low. This led the government to impose the new reimbursement rule, with the aim of reducing public expenditure on antihypertensive drugs.

Before the change, one in ten patients starting antihypertensive medication was prescribed a thiazide drug. This proportion gradually increased during the transition period, before stabilizing at one in four patients throughout the post-intervention period.

A slightly higher proportion of patients reached their recommended blood-pressure goal after the rule was introduced than before, though this small difference may have been due to chance. The fact that three-quarters of patients were still not getting thiazides indicates how hard it is to change what doctors prescribe.

CONTACT: Atle Fretheim Norwegian Knowledge Centre for the Health Services
'"/>




Page: 1 2

Related medicine news :

1. Reduction in melanoma death rate
2. A Reduction In Calories Found To Yield More Benefits
3. Weight Reduction Surgery Also Treats Metabolic Syndrome
4. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
5. A Change In Lifestyle Can Help In Weight Reduction
6. Fat isnt all that bad: Reduction no predecessor of reduced disease
7. MP’s Ask for Reduction of VAT on Condoms, Essential Health Ite
8. Drugs plus Awareness Would Facilitate Reduction of HIV Infection
9. Heart Disease Risk Halved By Minimal Cholesterol Reduction
10. Waiting Period Of Over 10yrs For Women Needing Breast Reduction Surgery
11. After Weight Reduction People Opt For Special Plastic Surgery to Tone Their Body
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reduction Drug Costs

Breaking Medicine Technology:Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Gail Harvey Promoted to Vice President of JH CVO 60046 1Gail Harvey Promoted to Vice President of JH CVO 60046 2New Online Tutorials for IMG IMG M NCBI Viral Genomes and VBRC 60043 1New Online Tutorials for IMG IMG M NCBI Viral Genomes and VBRC 60043 2New Online Tutorials for IMG IMG M NCBI Viral Genomes and VBRC 60043 3New Online Tutorials for IMG IMG M NCBI Viral Genomes and VBRC 60043 4Wellcome Trust funds dengue fever research in Leuven 10516 1Wellcome Trust funds dengue fever research in Leuven 10516 2